Lentiviral‐mediated gene transfer of brain‐derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge
暂无分享,去创建一个
[1] C. Coutelle,et al. Fetal and neonatal gene therapy: benefits and pitfalls , 2004, Gene therapy.
[2] Pierre Gressens,et al. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. , 2004, Cerebral cortex.
[3] G. Romano. Systems for regulated or tissue-specific gene expression. , 2004, Drug news & perspectives.
[4] P. Gressens,et al. Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain , 2003, Brain Research.
[5] P. Hüppi,et al. Diffusion tensor imaging of normal and injured developing human brain ‐ a technical review , 2002, NMR in biomedicine.
[6] Zeger Debyser,et al. Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. , 2002, Human gene therapy.
[7] P. Gressens,et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge , 2002, Annals of neurology.
[8] Philippe Colin,et al. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain , 2001, Nature Biotechnology.
[9] J. Volpe,et al. Perinatal brain injury: from pathogenesis to neuroprotection. , 2001, Mental retardation and developmental disabilities research reviews.
[10] P. Gressens,et al. Central Role of Microglia in Neonatal Excitotoxic Lesions of the Murine Periventricular White Matter , 2001, Brain pathology.
[11] Pamela L. Follett,et al. NBQX Attenuates Excitotoxic Injury in Developing White Matter , 2000, The Journal of Neuroscience.
[12] D. Holtzman,et al. BDNF Protects the Neonatal Brain from Hypoxic-Ischemic InjuryIn Vivo via the ERK Pathway , 2000, The Journal of Neuroscience.
[13] Luc Montagnier,et al. HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.
[14] I. Martins,et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] G Lynch,et al. Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons , 2000, The Journal of Neuroscience.
[16] J. Bloch,et al. Lentiviral Gene Transfer to the Nonhuman Primate Brain , 1999, Experimental Neurology.
[17] L. Acarín,et al. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: Astroglial response and metallothionein expression , 1999, Neuroscience.
[18] S. Apfel. Neurotrophic Factors in Peripheral Neuropathies: Therapeutic Implications , 1999, Brain pathology.
[19] P. Mestres,et al. Infusion of GDNF into the cerebral spinal fluid through two different routes: effects on body weight and corticospinal neuron survival , 1998, Neuroreport.
[20] O W Witte,et al. Long-term evolution of excitotoxic cortical dysgenesis induced in the developing rat brain. , 1998, Brain research. Developmental brain research.
[21] P. Gressens,et al. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. , 1997, The Journal of clinical investigation.
[22] A. Shah,et al. Marked age‐dependent neuroprotection by brain‐derived neurotrophic factor against neonatal hypoxic—ischemic brain injury , 1997, Annals of neurology.
[23] U. Lendahl,et al. An Evolutionarily Conserved Region in the Second lntron of the Human Nestin Gene Directs Gene Exmession to CNS Progenitor Cells and to Early Neural Ciest Cells , 1997, The European journal of neuroscience.
[24] P. Gressens,et al. Arrest of neuronal migration by excitatory amino acids in hamster developing brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] B Hagberg,et al. The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth‐year period 1995–1998 , 1996, Acta paediatrica.
[26] L. Wendt,et al. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987‐90 , 1996, Acta paediatrica.
[27] A. Björklund,et al. Generation of DOPA-Producing Astrocytes by Retroviral Transduction of the Human Tyrosine Hydroxylase Gene:In VitroCharacterization andin VivoEffects in the Rat Parkinson Model , 1996, Experimental Neurology.
[28] F. Gage,et al. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.
[29] J. Mallet,et al. An adenovirus encoding CuZnSOD protects cultured striatal neurones against glutamate toxicity , 1996, Neuroreport.
[30] R. Lindsay,et al. The NeurotroDhins BDNF, NT‐3 and NT‐4/5 Promote Survival and Morphological and Biochemical Differentiation of Striatal Neurons In Vitro , 1995, The European journal of neuroscience.
[31] P. Gressens,et al. Effect of Ibotenate on Brain Development: An Excitotoxic Mouse Model of Microgyria and Posthypoxic‐like Lesions , 1994, Journal of neuropathology and experimental neurology.
[32] Sanford H. Feldman,et al. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors , 1993, Nature Genetics.
[33] F. Silverstein,et al. Excitatory Amino Acids Contribute to the Pathogenesis of Perinatal Hypoxic‐Ischemic Brain Injury , 1992, Brain pathology.
[34] Michael V. Johnston,et al. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development , 1990, Brain Research Reviews.
[35] M. Johnston,et al. Neurotoxicity ofN-methyl-d-aspartate is markedly enhanced in developing rat central nervous system , 1988, Brain Research.
[36] Y. Arsenijévic,et al. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. , 2000, Human gene therapy.
[37] G. Innocenti,et al. Analysis of an Experimental Cortical Network: ii) Connections of Visual Areas 17 and 18 After Neonatal Injections of Ibotenic Acid , 1991, Journal of neural transplantation & plasticity.
[38] G. Innocenti,et al. Analysis of an Experimental Cortical Network: i) Architectonics of Visual Areas 17 and 18 After Neonatal Injections of Ibotenic Acid; Similarities with Human Microgyria , 1991, Journal of neural transplantation & plasticity.
[39] B. Delpech,et al. Hyaluronan and hyaluronectin in the nervous system. , 1989, Ciba Foundation symposium.